Skip to main content
. 2018 Oct 23;38(10):1717–1733. doi: 10.1038/s41388-018-0554-z

Fig. 1.

Fig. 1

Multiple inflammatory gene expression signatures are enriched in MEK inhibitor-resistant colorectal cancer cell lines. a Differential expression analysis (comparative marker selection, Morpheus, The Broad Institute) of basal gene expression profiles for KRAS-mutant colorectal cancer cell lines identified genes that were differentially overexpressed in cells resistant to the MEK inhibitor PD0325901 (top 50 genes shown). b Box and whisker plots representing the expression of candidate resistance genes in MEK inhibitor-sensitive versus MEK inhibitor-resistant cell lines. Box indicates the 25–75% percentiles and whiskers are the minimum to maximum values. c Gene set enrichment analysis (GSEA) of the rank-ordered, differentially expressed genes in MEK inhibitor-resistant cell lines identified an enrichment of multiple inflammation-related gene sets. d GSEA identified interferon response genes to be significantly enriched in the resistant cell lines (FDR < 0.001, p < 0.001). e Cells were treated with DMSO or 30 nmol/L trametinib for 3 d and cell lysates analyzed by western blotting for the indicated proteins